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Abstract 
Objective. To investigate the relationship between psychological representations of 
illness, perceived health status and self-assessment of symptom severity in patients 
with Behçet's Disease – a rare long-term incurable condition with unclear etiology. 
Methods. Using cross-sectional survey design, data on self-administered questionnaires 
on illness perception, health status, symptoms severity and demographic characteristics 
were collected from 273 patients with Behçet's Disease (age range 18 – 65+). The data 
were subjected to mediation analysis to test whether cognitive and emotional 
components of illness perception mediate the relationship between the severity of 
symptoms and heath status. 
Results. The results support our hypotheses that cognitive components of illness 
perception (perceived consequences and identity of the illness) mediate the link 
between symptom activity and pain, whereas emotional components of the illness 
(emotional representations about the illness) mediate the relationship between disease 
activity and perceived energy level. 
 Conclusion. The robustness of these mediation effects suggests potential directions for 
clinical psychologists and health care practitioners in developing support programmes. 
We supplement our study with Open Access database containing information about 
type of medication, comorbid mood disorder, detailed measurement of the severity of 
BD symptoms for sharing and accumulating multidisciplinary knowledge aiming to 
support the development of interventions. Addressing psychological aspects of BD will 
help to manage complex patients effectively. 
Key words 
Behçet's Disease; illness perception; mediation effect; pain, level of energy; the severity 
of symptoms 
Introduction 
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Each long-term condition can be characterised by a unique combination of 
psychological, physical and psychosocial factors. Understanding links between these 
factors is particularly important when there is no medical cure, and their quality of life 
heavily relies on self-regulation and coping strategies.  
One such long-term condition is Behçet's Disease (BD), also known as Behçet's 
Syndrome, a multi‐system disorder with unclear etiology. Although lower prevalence 
rates have been reported in a population of European ancestry [1] compared to Middle 
Eastern and Mediterranean descent [2,3], immigration and awareness among 
physicians have influenced an increased prevalence and diagnosis of BD in the UK [1]. 
It is only relatively recently that BD has received focused attention from the biomedical 
and health sciences, and therefore the psychological aspects of BD are still very poorly 
understood. The present paper aims to make a step toward understanding the 
relationship between psychological representations of illness, perceived health status 
and self-assessment of symptom severity in patients with Behçet's Disease. 
One useful framework for considering the mechanisms underlying perceived 
health outcomes is the Common Sense Model (CSM) [4,5]. Research on the CSM has 
indicated an emergent pattern of cognitive and emotional components of illness 
perception and the relationships between them that are specific to a particular illness 
[6,7].  
There are three unique aspects of BD that might shape the patients’ interpretive 
schema(s) of their illness. First, clinical manifestations of BD symptoms are overlapped 
with a number of chronic conditions such as systemic vasculitis, rheumatoid arthritis, 
autoimmune disease, recurrent oral ulcers [2]. In the majority of cases, patients are 
misdiagnosed several times prior to the correct diagnosis of BD being made [8]. 
Second, Behçet's Disease is classified as a rare disease [2], and as such is affected by 
a lack of both medical and non-medical information for both patients and practitioners. It 
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is known that as information becomes more widely and easily available, individuals are 
able to take a more active role in managing their illness [9,10].Third, BD pathogenesis 
involves profound inflammatory responses which are frequently associated with intense 
pain and unpredictable dynamics [11-13]. This sporadic pattern of BD activity can affect 
perceived health status in relation to pain [14]. Indeed, there is evidence that over 80% 
of patients with BD perceived their health status as having not enough energy [15], and 
were severely affected by the experience of pain [16].  
Research on Behçet's Disease indicates that both perceived energy level and 
pain significantly relate to the perceived severity of BD symptoms [16,17]. However, 
there is also evidence that the relationship between them may be mediated by different 
aspects of illness perception. For example, a number of studies in patients with Behçet's 
disease link their diminished energy level to a low level of emotional wellbeing, which in 
turn is related to their health self-assessment [16,18]. Studies on systemic vasculitis – a 
group of systemic diseases which share common clinical manifestations with Behçet's 
Disease - suggested that fatigue might be driven by negative emotional representations 
of the illness, concerns about illness outcomes and individual identification with the 
illness [18]. These findings, taken together, point to the possibility that emotional 
representations and concerns about the illness may mediate the relationship between 
the perceived severity of symptoms and energy level in patients with Behçet's Disease.  
There is a large body of research suggesting that patients’ attributions and 
beliefs about pain can modulate the level of perceived pain. For example, patients’ 
beliefs about the consequences of their condition on physical, social and emotional 
aspects of their life, showed a strong link with both the severity of symptoms and their 
quality of life [19-21]. Another aspect of BD patients’ beliefs may reflect that pain is the 
core feature (identity) of their illness. Although there is high degree of the variability of 
manifestations of Behçet's Disease, both between and within patients [22,23], one of the 
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most common features of BD is inflammatory reactions. As BD is characterized by 
recurrent episodes of acute inflammation, and often in new places, patients may 
perceive pain as the core identity of their illness.   
The findings above highlight the role of an illness perception in Behçet's Disease 
from the patients’ perspective and point at two important features. First, the relationship 
between the perceived severity of symptoms and perceived health status relating to 
pain and energy levels can be mediated by different components of illness perception. 
Second, cognitive representations about the illness (consequences of BD and symptom 
identification) may mediate the link between BD symptom activity and perceived pain, 
whereas emotional components of the illness perception (emotional representations and 
concerns about the illness) may mediate the relationship between the activity of BD and 
perceived energy level. The objectives of the present study were to test these two 
assumptions.  
Method 
Design and study sample 
This study adopted a cross-sectional online survey design. The board of trustees 
of the Behçet's Society in the UK reviewed the design and granted permission for the 
publication of the Survey Monkey web link to be posted on their social media sites 
alongside the generic website. This enabled a wider sample of participants to be 
recruited. Inclusion criteria stated that participants must be aged 18 or over and have a 
diagnosis of Behçet's Disease confirmed by their GP or Rheumatology Consultant.  
Data elements 
Using survey design, we collected data on (i) demographic information (age, gender 
and marital status); (ii) Behçet's Disease related information (Behçet's Disease Current 
Activity Form (BDCAF) [24]; (iii) self-assessment of the illness perception and heath 
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status (the Nottingham Heath Profile questionnaire [25], and the Brief Illness Perception 
questionnaire [26].  
Although medication and comorbid aspects of BD were not in a focus of this study, 
we provide open access database containing information about type of medication at 
the time of survey, comorbid mood disorder, detailed self-report assessment on the 
Behçet's disease Current Activity Form, the length of the disease duration from clinical 
diagnosis onset, the time of symptoms occurred prior a medical diagnosis 
(DOI 10.5281/zenodo.1251563). This information can provide a general picture about 
Behçet's Syndrome for general practitioners and clinical rheumatologists who are caring 
for BD patients. 
 
Materials 
The Behçet's Disease Current Activity Form (BDCAF) was developed and 
validated [27] to assess the severity of BD symptomology over the last four weeks. 
Summed scores on 12 items measure only disease activity (range 0-12). Previous 
research on the BDCAF has found good inter-observer reliability for assessing general 
disease activity in British patients.  
The Brief Illness Perception Questionnaire (Brief-IPQ) is a 9-item questionnaire 
designed to rapidly assess cognitive and emotional representations of illness. The Brief-
IPQ showed good test-retest reliability (0.24-0.73) across a wide range of chronic 
diseases, including vasculitis and rheumatoid arthritis. The discriminant validity of the 
questionnaire was supported by its ability to distinguish between different illnesses 
including different types of vasculitis, and has advantages in terms of brevity and lower 
participant burden [28].  
The Nottingham Health Profile Questionnaire (NHP) contains 38 items included 
in Part I and seven optional items that comprise Part II. For statistical analyses, we used 
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only Part I. Internal consistencies (Cronbach’s α) for the NHP (Part I) were reported as 
following: .63 for Energy level, .81 for Pain, .81 for Emotional Reactions, .76 for Sleep, 
.65 for Social Isolation, and .80 for Physical Abilities [29]. 
Procedure 
An information sheet explaining the purpose, content, data use, withdrawal from 
the study, consent page and details about the researchers preceded the survey. After a 
participant’s agreement was received, they were taken into the survey.  
During recruitment, the randomness of participants’ age, gender, and duration of the 
disease was assumed, but it was not under control due to the small population of 
people suffering from BD.   
Data Analysis 
Three analyses were performed in this study. First, we analysed the 
demographic characteristics of the sample and the type and number of BD symptoms. 
Secondly, we analysed concerns with characteristics of the illness perception and 
perceived health status in our sample. In the third analysis, we modelled the relationship 
between BD symptom severity (independent variable), illness perception (mediator) and 
the NHP (the outcome variable) using a mediation approach. All statistical analyses 
were done using the computing environment R (R Development Core Team, 2005), 
lavaan package [30]. 
Participants  
In total, 273 adults with a confirmed Behçet's Disease diagnosis participated in 
the present study. After inspection of the data, 23 participants were removed due to an 
incomplete or partly completed survey. The data from the remaining 250 participants 
were selected for the analyses. 
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For analysis of demographic characteristics of the sample, the data were 
collapsed across four age categories: 18-29, 30-44, 45-59 and over 60 years old. Table 
1 summarises the sample characteristics with respect to age and sex. 
 The distribution of sample by age category, disease duration and symptom onset 
before medical diagnosis of BD and discussion are reported in the Supplementary 
Material, Section 1. 
Results 
Behçet's Disease Current Activity 
The average BDCAF score for the sample was 6.29, SD = 2.4. Symptoms 
assessed by BDCAF and the number of respondents who experienced these symptoms 
are presented in Table 2. 
Illness perception and Health Profile 
Previous research demonstrated that beliefs about an illness’s etiology might 
affect patients’ emotional responses, particularly in illnesses in which the etiology is 
unclear [31]. To identify the most common factors that BD patients attribute to their 
illness, we analysed individual responses for an open question requesting participants 
to indicate three factors that they believe caused their illness. The results are displayed 
in Figure 1. 
The average profile of illness perception and perceived health status in BD 
patients are displayed in Figure 2.  
An additional analysis assessing whether illness perception in BD patients differs 
from other people suffering from chronic conditions and discussion are reported in the 
Supplementary Material, Section 2. It has to be noted that the pattern of illness 
perception and health status were consistent across age and the different length of BD 
(Supplementary Material, Section 3). 
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Modelling the relationship between BD symptom severity, illness perception and 
the NHP  
To answer the question of whether illness perception mediates the relationship 
between the severity of BD symptoms and perceived health status we first assessed 
associations between the symptom severity, and the NHP. The severity of BD 
symptoms and the NHP showed significant correlations with Consequences, Identity, 
Concerns and Emotional Representation subscales of the Brief IPQ (Table 3). These 
subscales of illness perception were entered as potential mediators in the mediation 
models with the severity of BD symptoms as the independent variable, and two 
subscales of perceived health status (Pain and Energy level) as the dependent 
variables. 
Two modelling procedures were carried out: Model 1 and Model 2 (Figure 3). In 
Model 1, we tested an assumption that the relationship between the severity of BD 
symptoms and perceived Pain is mediated by Consequences and Identity of illness 
perception (cognitive components of illness perception), but not by Emotional 
Representation and Concerns (emotional components of illness perception). In Model 2, 
we tested the assumption that the association between symptom severity and perceived 
Energy level in BD patients is mediated by emotional components of illness perception 
(Emotional Representation and Concerns), but not by cognitive components 
(Consequences and Identity) of illness perception. Including both cognitive and 
emotional components of illness perception in initial models allow us to compare the 
effects of all mediators while accounting for covariance between them [32]. 
  The modelling was performed in two steps. First, we specified all possible 
relationships between estimated parameters in each model and ran the models. The 
variances for each variable and all covariance terms between each pair of variables 
were added to the models. After inspecting the parameters of these initial models, we 
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tested final models. To examine the indirect effects, we used the product-of-coefficients 
tests (see for details in Supplementary Material, Section 4).  
Models fit. There were no missing data. To estimate fitting parameters, we chose 
weighted least squares (WLS) because the data were not distributed normally. The 
initial models which included all possible covariation terms between the mediators 
showed bad fit. After an inspection of the covariance matrices and removing non-
significant ones (covariance between Consequences and Concerns, and Identity and 
Concerns), the hypothesized models appear to be a good fit to the data. Fit parameters 
for Model1 were: (χ2 = 1.968, p(χ2) = .161; the comparative fit index (CFI) = 0.992; the 
RMSEA (Root Mean Square Error of Approximation) = 0.062, 90%CI [0.000, 0.193]; the 
SRMR (Standardized Root Mean Square Residual) = 0.011. Fit parameters for Model 2 
were: (χ2 = 1.968, p(χ2) = 0.161; CFI = 0.988; the RMSEA = 0.062, 90%CI [0.000, 
0.193]; the SRMR = 0.012.  
Mediation models. Mediation is said to occur if an indirect effect contributes 
significantly to the model estimation (defined by subtracting the direct effect from the 
total effect) [33]. Therefore, mediation is present if the confidence interval of the indirect 
path does not contain zero. The results of mediation analyses are summarized in Table 
4.  
The results of mediation analyses (Table 4) indicate that in both models only 
indirect effects reached a significance level. For substantive interpretation of the results, 
we next report the unstandardized regression coefficients a, b, and c. In Model 1, the 
indirect path BDCAD -> Consequences -> Pain (a1xb1 in Figure 3, Model 1) indicates 
that a unit increase in the severity of BD symptoms increases 0.4 units of perception of 
illness consequences, which leads to increasing perceived pain by 4.9 units. In the 
indirect path BDCAD -> Identity -> Pain (a2xb2 in Figure 3, Model 1), a unit increase in 
the severity of BD symptoms increases identification with the disease by 0.3 units, 
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which elevates the level of perceived pain by 4.5 units. Notably, no significant direct 
effect (BDCAF -> Pain) was observed here (Table 4), suggesting the mediating role of 
illness perception. 
In Model 2, the indirect path BDCAD -> Emotional representation -> Energy 
(a4xb4 in Figure 3, Model 2), indicates that a unit increases in BD symptom severity 
facilitates emotional representations of illness by 0.3 units, which leads to perceived 
tiredness increasing by 3.1 units. Similar to Model 1, the direct effect (BDCAF -> 
Energy) was non-significant, suggesting the mediating effect of emotional 
representations between the severity of symptoms and reported energy level in BD 
patients.  
 
 
Discussion 
In the present study, we make a step toward understanding the relationship 
between psychological representations of illness, perceived health status and self-
assessment of symptom severity in patients with Behçet's Disease. 
The CSM suggests that acting as a scientist, a patient may use the unexplained 
causality in BD as a heuristic for reducing the level of frustration [4]. Over 16% of BD 
respondents in our study linked the cause of their illness to unsuccessful surgical 
procedures, pregnancy, abused parenteral behavior in their childhood, “bad luck” and 
“fate”, and medical negligence. It is well known that causal illness attributions influence 
emotional reactions, physical self-concept, coping strategies, illness behavior and 
comorbid mood disorders [34]. Addressing these issues by facilitating information 
awareness in BD patients about causes of the illness may help to reduce the number of 
misattributions to the causes of Behçet's Disease. 
We hypothesized that the relationship between the severity of Bechet’s Disease 
symptoms and health status related to pain and energy level is influenced by different 
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components of illness perception and tested this assumption by using a mediation 
approach. Two important findings emerged from our analyses. The first is that we 
confirmed our hypothesis and provided evidence that cognitive components of illness 
perception mediated the relationship between perceived pain and the severity of BD 
symptoms. The relationship between energy level and the severity of BD symptoms 
was mediated by emotional, but not cognitive components of illness perception.  
Our correlation analysis showed significant positive association between the 
BDCAF scores and either Pain and Energy scores of the NHP, indicating that with 
increasing symptom severity, the levels of perceived pain and tiredness also increase. 
These results point to the presence of a direct effect between symptom severity and 
perceived health status. However, this direct effect disappeared once we modelled the 
relationship between these variables as indirect paths via illness perception (the total 
effects in Model 1 and Model 2 remained significant while the direct effects were not), 
suggesting an indirect-only mediation [35], which is considered as the strongest 
demonstration of mediation occurring [36]. 
Importantly, both perception of illness consequences and representation of 
illness identity mediate the relationship between the severity of BD symptoms and 
perceived pain, and we found no significant difference in the ‘strength’ of the mediation 
effect between them. Furthermore, neither the control-related dimensions, including 
representations of the length of the disease and understanding the illness, nor 
emotional-related dimensions showed mediation effects. This finding may have practical 
implications. For example, knowing that perception of consequences and identification 
of illness symptoms in patients with Behçet's Disease mediate perceived pain, 
interventions may focus on changing these mediating variables to affect behavior and 
perceived quality of life. 
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Mediation analysis in the present study demonstrated that emotional 
representations but not concerns about the illness mediate the relationship between 
BDCAF scores and perceived energy level. Only indirect effect ‘BDCAF – emotional 
representations – energy’ was significant. This finding suggests that negative emotional 
representations about the illness may facilitate feelings of tiredness and lack of energy. 
In contrast to our assumption, there was no mediation effect of concerns about the 
illness on energy level (Model 2) or pain (Model 1). This finding may indicate that 
illness-related concerns in BD patients are not a function of the emotional component of 
illness perception but emerged as a function of the perceived severity of the disease 
and are associated with energy level directly or via other dimensions of illness 
perception.  
Our study provides findings of mediation effects of illness perception on 
perceived health status, which can be used by heath providers for the development of 
interventions to help people suffering from Behçet's Disease. Considering that Behçet's 
Disease is classified as a rare disease, and there were 1,221 patients registered in the 
UK by December 2015 [37], the study sample is representative of the general 
population.  
Directions for practical implications of the results and further research are 
outlined in Supplementary Material, Section 5. 
Limitations of the present study 
First, our data are based on self-reported diagnosis. However, demographic 
characteristics, the disease symptoms, types of medications, perceived health status 
and symptom severity were consistent with previous papers on Behçet's Disease. 
Furthermore, we provide raw data in the Open Access Repository which includes all 
variables and additional information about the sample in our study. By providing the raw 
data, we encourage other researchers to create a database which could be useful for 
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accumulating existing knowledge about psychological, medical and socio-demographic 
aspects of Behçet's Disease, and supporting the development of interventions.  
Second, all variables in the present study were measured using validated (and 
accepted by the NHS) measurements of perceived health status, illness perception and 
the severity of Behçet's Disease. However, due to the majority of the data being 
collected using an online survey, there was a chance of residual confounding.  
Third, a prevalence of female respondents over males in our study was 5.4 : 1. 
Although the previous study in the UK with a larger sample size reported similar sample 
characteristics (22), it may not be representative for groups of BD patients in other 
countries. 
Fourth, the design of our study is cross-sectional and therefore, possesses the 
limitations of this design. However, due to the nature of the variables that were taken 
into mediation analyses, it is unlikely that our findings reflect any ‘time-limited’ 
relationship between the variables.  
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Figure legends 
Figure 1. Patients’ beliefs of the causes of their illness 
 
Figure 2. Illness perception (CQ – consequences of illness, TL- timeline of illness, PC - 
personal control, TR – treatment control, ID – identity of illness, CS – concerns, UN – 
understanding illness, ER – emotional representations). Health status (P – pain, SL – 
sleep, ER – emotional reactions, MB – mobility, SI – social isolation, EN – energy). 
Error bars represent +/-SEM 
 
Figure 3. Models tested in the present study. BDCAF – severity of BD symptoms - 
independent variable; Illness perception (Consequence, Identity, Emotional 
Representation, Concerns) are mediators; the NHP (Pain and Energy level) are 
dependent variables; a1-a4 in each model represent the effects of the independent 
variable on the mediators; b1-b4 represent the effects of the mediators on the 
dependent variables; c represents the direct effect of the independent variable on the 
dependent variables. Plain lines outline the main hypothesis tested in each model. 
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Table legends 
 
Table 1. Distribution of the sample by age category and sex 
Table 2. BDCAF symptoms (N = 250, fem = 211).  
Table 3. Associations1 between BD symptom severity (BDCAF), illness perception CQ – 
consequences of illness, TL- timeline of illness, PC - personal control, TR – treatment 
control, ID – identity of illness, UN – understanding illness, CS – concerns, ER – 
emotional representations) and health status (P – Pain, SL – sleep, ER – Emotional 
Reactions, MB – Mobility, SI – Social Isolation, EN – Energy) 
 
Table 4. Summary of mediation analyses for Model 1 and Model 2. IV-independent 
variable; DV - dependent variables; BDCAF - severity of BD symptoms; P-Pain, EN = 
Energy level, CQ = Consequences, ID - Identity, ER - Emotional Representation, CS - 
Concerns 
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Supplementary Material 
Illness perception mediates the relationship between the severity of symptoms 
and perceived health status in patients with Behcet’s disease 
Yankouskaya A, Boughey A, McCagh J, Neal A, de Bezenac C,  Davies SJ 
 
Section 1. Distribution of sample by age category and symptom onset before 
medical diagnosis of BD 
Table S1. Distribution of sample by age category and symptom onset before 
medical diagnosis of BD 
 Disease duration  
Age 
1 - 5 
years 
6 - 10 
years 
11 - 15 
years 
15 + 
years Total 
18-29 29 14 2 1 46 
30 - 44 59 21 12 14 106 
45 - 59 35 17 8 21 81 
60+ 5 2 1 9 17 
Total 128 54 23 45 250 
 
Table S2. Distribution of sample by age category and disease duration (after 
receiving the diagnosis) 
 Disease duration  
Age 
1 - 5 
years 
6 - 10 
years 
11 - 15 
years 
15 + 
years Total 
18-29 22 12 8 4 46 
30 - 44 29 14 15 48 106 
45 - 59 12 14 12 43 81 
60+ 0 0 1 16 17 
Total 63 40 36 111 250 
 
It has to be noted that the majority of existing research on BD focuses on 
medical aspects of its symptomology and reports a duration of disease from the 
time of medical diagnosis. However, our data indicate that symptom onset occurs 
much earlier (Tables S1 and S2), almost doubling the time of its impact on well-
being. Although progress has been made in clarifying diagnostic criteria for BD, 
medical decisions are mainly based on specific patterns of symptoms. In the case of 
 20 
incomplete patterns, the diagnosis and therefore, an appropriate treatment, is delayed 
to rule out any other causes of these symptoms. This fact needs to be taken into 
account when assessing a patient’s health profile and the impact of BD on well-being.  
Section 2. Whether illness perception in BD patients differs other people suffering 
from chronic conditions 
Previous research indicated that illness perceptions are purported to be disease-
specific. To examine whether illness perception in BD patients differs from other people 
suffering from chronic conditions, we performed analysis of variance (ANOVA) using 
summary data (N – sample size, M – mean, and SD – standard deviation) from 
published studies (Table S3). One of the studies was selected based on symptoms 
shared with BD patients (rheumatoid arthritis) [1]. The second study had patients with 
life-threatening conditions (cardiovascular and ischemic heart diseases) [2]. Both 
studies had similar sample characteristics.  
 
Table S3. Average profile of illness perception in BD patients in the present study 
(Group 1, N=250) and two groups of patients with long-term conditions from previous 
studies: Rheumatoid arthritis patients (RA, Group 2, N=292) and cardiovascular disease 
(CVD/IHD, Group 3, N=235).  
Illness* 
perception 
Group 
1 
 
Group 
2 
Group 
3 
ANOVA 
F(2,774) 
**Tukey HSD Post-hoc Test 
D=difference 
CI =99%confidence interval 
CQ  7.62 
(2.2) 
 
7.14 
(2.3) 
7.68 
(2.4) 
4.51 
p=.01 
Group 1 vs Group 2: D=0.48, CI 
[-0.1; 1.1], p= .04 
Group 1 vs Group 3: D=-0.06, CI 
[-0.67; 0.55], p=.9 
TL  8.81 
(2.3) 
 
 
8.27 
(2.6) 
6.21 
(2.2) 
80.7 
p<.001 
Group 1 vs Group 2: D=0.54, CI 
[-0.06; 1.4], p=.02 
Group 1 vs Group 3: D=2.6, CI 
[1.9; 3.2], p<.001 
PC 3.22 
(2.2) 
 
 
7.25 
(2.0) 
3.76 
(1.5) 
350.6 
p<.001 
Group 1 vs Group 2: D=-4.03, CI 
[-4.5; 3.5], p<.001 
Group 1 vs Group 3: D=-0.54, CI 
[-1.1;0.03], p=.006 
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TR  4.43 
(2.8) 
 
 
8.21 
(1.8) 
6.26 
(0.9) 
242.3 
p<.001 
Group 1 vs Group 2: D=-3.8, CI [-
4.28;3.27], p<.001 
Group 1 vs Group 3: D=-1.8, CI [-
2.4; -1.3], p<.001 
ID  7.57 
(1.9) 
 
 
5.92 
(2.2) 
4.39 
(0.9) 
190.2 
p<.001 
Group 1 vs Group 2: D=1.65, CI 
[1.19; 2.1], p<.001 
Group 1 vs Group 3: D=3.2, CI 
[2.7;3.65], p<.001 
UN  6.56 
 (2.8) 
 
 
5.89 
(2.7) 
3.7 
(1.5) 
91.2 
p<.001 
Group 1 vs Group 2: D=0.7, CI 
[0.05; 1.3], p=.004 
Group 1 vs Group 3: D=2.9, CI 
[2.2;3.5], p<.001; 
CS  7.9  
(2.2) 
 
 
7.86 
(2.6) 
7.38 
(2.6) 
3.5 
p=.03 
Group 1 vs Group 2: D=-0.01, CI 
[-0.6; 0.6], p=.9; 
Group 1 vs Group 3: D=-0.5, CI [-
1.2; 0.14], p=.06 
ER  
 
7.5  
(2.4) 
 
 
6.27 
(3.1) 
4.27 
(0.9) 
112.4 
p<.001 
Group 1 vs Group 2: D=-1.2, CI [-
1.8; -0.6], p<.001 
Group 1 vs Group 3: D=-3.2, CI [-
3.8; -2.6], p<.001 
*CQ – consequences of illness, TL- timeline of illness, PC - personal control, TR – 
treatment control, ID – identity of illness, UN – understanding illness, CS – concerns, 
ER – emotional representations 
**Tukey’s HSD Post Hoc test (with the harmonic mean of n-sizes as n to compare 
groups with unequal sample sizes) was used to maintains alpha levels for multiple tests  
 
Table S2 indicates that illness perception in BD patients differs from patients 
suffering from RA and CVD/IHD. BD people showed significantly lower personal control 
over the illness and treatment, higher emotional response, identification with the illness 
and understanding. The most striking differences reflect emotional representations 
about the illness and perception of illness identity. Patients with BD are significantly 
more emotionally distressed compared to patients with rheumatoid arthritis and vascular 
diseases. This negative emotional perception of illness is noteworthy, as it has been 
shown to negatively influence emotional adjustment, health-related outcomes and non-
adherence to treatment across other severe [3] and chronic illness populations [4,5]. 
Previous research linked patients’ beliefs about the impact of their illness on emotional 
wellbeing to negative interpretations of the situation (catastrophizing), illness threats, 
perceived availability of support from close people, and economic and family problems 
attributed to illness [6]. To date, no studies have looked specifically at core factors 
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triggering negative emotional reactions in BD patients that limits the development of 
health care provision, and psychological and social care services.  
One of the cognitive mechanisms underlying developing coping strategies in 
patients with a long-term condition is determining psychological ownership of the illness. 
It was suggested that the epiphanic moment of diagnosis is a significant life event that 
led down the path of identity reconstruction, interpretation, and acceptance of the reality 
of living with a long-term condition which are important prerequisites in coping with the 
consequences of a disease on a daily basis [7]. As an individual reflexively interprets a 
long-term condition as a part of ‘the self’, the identification with a long-term illness is 
fixed as an idea of control over the illness [8] and responsibility towards the disease 
state, resulting in an enhanced sense in maintaining or protecting one’s identity.  
The results of our study suggest that illness perception in BD patients is 
associated with low personal control over the illness1. The level of personal control in 
our BD patients (3.22 +/-2.2) is significantly lower compared to groups of patients with 
other long-term condition (7.25+/-2.0; 3.76+/-1.5). However, the perception of the illness 
identity showed the opposite pattern (7.57+/-1.9 in BD patients compared to 5.92+/-2.2 
and 4.39+/-0.9 in RA and CVD patients respectively). Moreover, we found a weak but 
significant negative correlation between the level of personal control and illness identity 
(r=-0.23, p<.001, BCa 95% CI [-0.353, -0.114]). This finding indicates that the more 
symptoms BD patients attribute to the illness, the less control they feel over the illness, 
and, as a result, decreasing the development of coping mechanisms. Although the low 
level of perceived personal control in BD patients may, partly, stem from medical issues 
(such as the delayed diagnosis, unclear causes of the disease and triggering factors), 
the role of clinical psychologists in facilitating CBT and online guided self-help 
                                                 
1 Similar result is reported in Grayson et al., 2013 
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programmes on developing adaptive coping strategies in patients with BD will be 
invaluable.  
 
Section 3.  
 
3.1 The effects of illness duration on illness perception in BD patients 
 
Separate analyses of variance were performed to test the effect of illness 
duration on cognitive and emotional aspects of illness perception. Participants were 
divided into 4 groups based on the duration of BD (after medical diagnosis): up to 5 
years, from 6-10 years, from 11-15 years, and over 15 years.  The average scores of 
illness perception in each group are displayed in Figure S1 
 
Figure S1. Average scores of illness perception in four groups BD participants. Error 
bars represent +/- SEM 
 The results of eight between-subject ANOVAs are summarized in Table S3.  
Post Hoc tests using Bonferroni adjustment for multiple comparisons revealed 
that there was a significant difference between 11-15 years duration and 15+ years 
(p=.005) for consequence (CQ) and between 0-5 years and 15+ years (p=.009) for 
timeline (TL). No other significant terms were found here. 
Table S3. The results of between-subject ANOVAs comparing the difference in eight 
dimensions of illness perception between four groups of participants (with 0-5 years of 
BD disease, 6-10 years, 11-15 years and over 15 years) 
  
Sum of 
Squares 
df 
Mean 
Square 
F Sig 
*Post Hoc 
analysis 
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IP_CQ 38.37 3 12.79 2.81 0.04 11-15 vs 15+ years, p=.005 
IP_TL 53.01 3 17.67 3.61 0.014 0-5 vs 15+ years, p=.009 
IP_PC 15.03 3 5.01 1.02 0.39 n.s 
IP_TR 25.33 3 8.44 1.09 0.35 n.s 
IP_ID 10.39 3 3.47 0.95 0.42 n.s 
IP_CS 27.63 3 9.21 2.0 0.11 n.s 
IP_UN 8.82 3 2.94 0.36 0.78 n.s 
IP_ER 5.16 3 1.72 0.3 0.82 n.s 
*p-values are adjusted using Bonferroni correction 
3.2. The effects of illness duration on perceived heath status (measured by the NHP) in 
BD patients 
 
Figure S2. Average scores of perceived health status in four groups BD participants 
with different length of BD duration. Error bars represent +/- SEM 
 
Separate ANOVAs were carried out to test the effect of the disease duration on 
the NHP dimensions. These analyses are summarized in Table S4. 
Table S4. The results of between-subject ANOVAs comparing the difference in six 
subscales of perceived health status in BD patients (with 0-5 years of BD disease, 6-10 
years, 11-15 years and over 15 years) 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig 
NHP_P 9833.63 3 3277.86 2.79 0.041 
NHP_SL 3046.84 3 1015.61 1.1 0.35 
NHP_ER 3530.55 3 1176.85 1.85 0.139 
NHP_PhA 2212.55 3 737.52 0.982 0.402 
NHP_SI 4701.65 3 1567.22 1.73 0.162 
NHP_EN 1202.37 3 400.79 0.757 0.519 
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Post Hoc test with Bonferroni correction for multiple comparisons showed no 
significant difference across the disease duration for each NHP subscales. 
 
 
Section 4 
 
Prior to the modelling of data, we assessed multicollinearity between the 
outcome variables by estimating variance inflation factors (VIF). The VIF estimates how 
much variance of the estimated regression coefficient is “inflated” by the existence of 
correlation amongst the independent variables in the model: 
VIF=1/(1−R2), 
where the denominator is the percent of variance in the predictor that cannot be 
accounted for by other predictors.  
A VIF of 1 means that there are no correlations among an X(i) predictor and the 
remaining predictor variables, and hence the variance of the regression coefficient is not 
inflated. If a VIF exceeds 4, a further investigation of multicollinearity is needed.  
4.1 Assessing the assumption of multivariate normality for mediation analyses 
 
Assessing the assumption of multivariate normality was performed using the 
MVN package in R (version 4.0.2). We report here Mardia’s test to compute multivariate 
skewness and kurtosis coefficients as well as their corresponding statistical 
significance.  
Table S5. Summary of multivariate normality test MVN  
   g1p               : 34.42962  
   chi.skew       : 1434.568  
   p.value.skew   : 4.651011e-56  
   g2p                 : 271.1246  
   z.kurtosis        : 5.644752  
   p.value.kurt    : 1.654193e-08  
   chi.small.skew : 1453.955  
   p.value.small  : 2.684789e-58  
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Table S5 indicates that the skewnwss (denoted as g1p) and kurtosis (denoted as 
z.kurtosis) do not indicate multivariate normality. To inspect the data, we created Chi-
Square Q-Q plot (Figure S3). 
 
Figure S3. Chi-Square Q-Q plot for mediation data set.  
Figure S3 indicates some deviations from the straight line suggesting possible 
departures from a multivariate normal distribution. Taken together, we can conclude that 
our data do not satisfy MVN assumption of multivariate normality.  
4.2 Modelling mediation effects 
To examine the indirect effects, we used the product-of-coefficients tests, where 
the estimates of the indirect effects are divided by its standard error. The estimates of 
the individual mediated effects can then be summed to form an estimate of the total 
mediated effect. The main limitation of the product-of-coefficients tests is that the 
resulting statistics are compared with a normal distribution to test for significance. The 
sampling in our study violates the assumption of multivariate normality (Table S5, 
Figure S3), and therefore, leaving the chance that the product of two non-normally 
distributed variables will also violate the assumption of normality. To overcome this 
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issue, we used bootstrapping, a nonparametric method that does not assume that the 
distribution of the product is normal. 
Section 5 
Directions for practical implications of the results and further research: 
1. Consequences are cognitive representations of illness reflecting patient’s beliefs 
of how much the illness affects his/her life. A number of studies have demonstrated 
that greater perception of an illness influence is associated with dysfunctional coping 
strategies in response to illness-related stressors [9], avoidance coping strategies [10], 
diminished help-seeking behavior [11], and mental and behavioural disengagement 
[12]. Interventions aiming to adapt the perception of consequences to be more realistic 
and, possibly, separating them from emotional representations, may help to enhance 
adaptive coping mechanisms in patients with BD. 
2. Advances in current medical and health care practice have made progress in 
terms of the diagnosis, pathogenesis and etiology of BD. However, there are still no 
specific diagnostic tests. Furthermore, various diagnostic criteria have been proposed 
around the world. As the clinical expressions of Behçet's Disease are heterogeneous, 
there is a chance to misrepresent symptoms of the disease as either comorbid or a 
short-term illness unrelated to BD (e.g., mouth ulcers caused by a number of other 
conditions). These misrepresentations may lead to misidentification of the disease 
symptoms resulting in the elevated perception of BD identity. This may explain high 
scores on the perception of illness identity in BD patients (7.57) compared to other 
long-term conditions (5.93, 4.39) in our study. 
3. Our data showed a strong positive correlation between perception of the illness 
consequences and perception of illness identity (r=.61, p <.001, 95% BCa CI [.49, .69]) 
and both dimensions showed a mediation effect on perceived pain. This relationship, 
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potentially, may be considered as a target for CBT for BD patients. Targeting 
perception of the disease identity and perception of the anticipated consequences of 
Behçet's Disease may reduce sporadic pain-related psychological and physical 
functions, both alone and as an adjunct to other treatment. 
4. Mediation analysis in the present study demonstrated that in contrast to our 
hypothesis that both concerns and emotional representations about the illness mediate 
the relationship between BDCAF scores and perceived energy level, only indirect effect 
‘BDCAF – emotional representations – energy’ was significant. This finding suggests 
that negative emotional representations about the illness may facilitate feelings of 
tiredness and lack of energy. The importance of this finding reflects a strong 
relationship between emotional representations of illness and coping strategies which 
may be used in planning Cognitive Behavioural (CB) Interventions with a BD cohort. Of 
potential interest for the CB interventions may be specific emotions underlying these 
emotional representations about Behçet's Disease (e.g., embarrassment, guilt, 
sadness). Such emotions are easily assessed and likely to have different antecedents, 
although no studies have sought to examine the cognitive antecedents of these 
emotions in BD patients yet. Further studies may aim to address this gap. 
5. The relationship between variables in our study reflects a patients’ 
perspective, which can be different from a health providers perspective. 
Performing research where both perspectives can be compared or taken into 
account will provide better understanding between patients with Behçet's 
Disease and health providers, and as a result, better treatment outcomes. 
6. Behçet's Disease is a long-term condition with unclear etiology, disease 
pattern, treatment outcomes and life expectancy. People who live with this 
disease need support from partners, family, friends, and relatives. At this time 
we have a limited understanding of the role of close social support in alleviating 
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the impact of negative emotional appraisal in BD patients. Research linking the 
effects of social support, negative emotional appraisal, and life satisfaction will 
help to facilitate programmes for both patients to enable them to do the things that 
are important to them and their families, and their close support network to develop 
skills necessary to provide support for individuals with BD.     
7. Longitudinal work is needed to assess the dynamics of illness perception, quality 
of life and symptom severity to design interventions for the improvement of 
psychological health among people with Behçet's Disease. 
References 
1. Young SS, Yun-Hong C, Hyun-Ok K, Rock-Bum K, Ki Soo Park, Sang-Hyon Kim, 
Seung-Geun L, Eun-Kyoung P, Jian H, Sang-Il Lee. Medication nonadherence in 
Korean patients with rheumatoid arthritis: the importance of belief about 
medication and illness perception. Korean J Intern Med. 2018; 33(1): 203–210. 
2. Kholid RMN, Tippamas C, Charuwan K. Illness perception and cardiovascular 
health beahviours among persons with ischemic heart disease in Indonesia. 
International Journal of Medicine, Health and Food Sciences 2017; 1(2):33-42. 
3. Millar K, Purushotham AD, McLatchie E, George WD, Murray GD. A 1-year  
prospective study in individual variation in distress and illness perceptions, after 
treatment for breast cancer. J Psychosom Res 2005; 58:335-42. 
4. Zoeckler N, Kenn K, Kuehl K, Stenzel N, Rief W. Illness perceptions predict 
exercise capacity and psychological well-being after pulmonary rehabilitation in 
COPD patients. J Psychosom Res. 2014; 76(2):146-51. 
5. Cherrington CC, Moser DK, Lennie TA, Kennedy CW. Illness representation after 
acute myocardial infarction: impact on in-hospital recovery. Am J Crit Care 2004; 
13(2):136-45. 
6. Dempster M, McCorry NK, Brennan E, Donnelly M, Murray LJ, Johnston BT. 
Psychological distress among family carers of oesophageal cancer survivors: the 
role of illness cognitions and coping. Psycho-Oncology 2011; 20: 698-705. 
7. Karnilowicz W. Identity and psychological ownership in chronic illness and 
disease state. Eur J Cancer Care (Engl). 2011; 20(2):276-82. 
8. Clarke JN, James S. The radicalized self: the impact on the self of the contested 
nature of the diagnosis of chronic fatigue syndrome. Social Science and 
Medicine 2003; 57:1387–1395. 
9. Norcini PA, Steca P. Illness perceptions and coping strategies among individuals 
diagnosed with HIV.J Behav Med. 2015; 38(4):620-31. 
10. Awasthi P, Mishra RC. Role of coping strategies and social support in perceived 
illness consequences and controllability among diabetic women. Psychology and 
Developing Societies 2007; 19:179-197.  
11. Vogel, DL, Wester SR, Larson LM. Avoidance of Counseling: Psychological 
Factors That Inhibit Seeking Help. Journal of Counseling & Development 2007; 
85(4): 410-22. 
 30 
12. Morgan k, Villiers-Tuthill A, Barker M, McGee M. The contribution of illness 
perception to psychological distress in heart failure patients. BMC Psychol. 2014; 
2(1): 50. Published online 2014 Nov 28.   
 
Figure1 Click here to download Figure Figure 1.tiff 
Figure2 Click here to download Figure Figure 2.tiff 
Figure3 Click here to download Figure Figure3.tiff 
Table 1. Distribution of the sample by age category and sex 
Sex 
Age Female Male Total 
18-29 39 7 46 
30 - 44 87 19 106 
45 - 59 72 9 81 
60+ 13 4 17 
Total 211 39 250 
Table
Table 2. BDCAF symptoms (N = 250, fem = 211).  
Symptom Symptom 
presence 
Females Males Total Missing 
responses 
Headache no 69 18 87 1 
 yes 141 21 162 0 
Mouth ulcer no 59 21 80 0 
 yes 152 18 170 0 
Genital ulcer no 100 31 141 0 
 yes 101 8 109 0 
Erythema no 144 30 174 0 
 yes 67 9 76 0 
Pustules no 98 19 117 0 
 yes 113 20 133 0 
Joints Arthralgia no 87 20 107 0 
 yes 124 19 143 0 
Nausea/ 
Abdominal pain 
no 74 26 100 0 
 yes 137 13 150 0 
Diarrhoea no 127 26 153 0 
 yes 84 13 97 0 
      
 
  
Table 3. Associations1 between BD symptom severity (BDCAF), illness perception 
CQ – consequences of illness, TL- timeline of illness, PC - personal control, TR – 
treatment control, ID – identity of illness, UN – understanding illness, CS – concerns, 
ER – emotional representations) and health status (P – Pain, SL – sleep, ER – 
Emotional Reactions, MB – Mobility, SI – Social Isolation, EN – Energy) 
P SL ER MB SI EN BDCAF 
ICQ 2.53** .26* .22 .43** .27* .42** .41** 
TL .10 -.01 .11 -.02 .11 .13 .21 
PC -.08 -.08 -.13 -.06 -.24 -.15 -.23 
TR -.03 -.11 -.22 -.00 -.14 -.06 .05 
ID .50** .25* .23 .43** .22 .37* .41** 
CS .28* .20 .21 .30* .21 .44* .23* 
UN .05 -.12 -.19 .02 -.12 .01 .03 
ER .28* .24 .38** .26* .35** .49** .36** 
BDCAF .33* .19 .18 .22 .19 .28* 
1 Pearson correlation coefficient with Bonferroni correction of alpha .05/N of tests 
(=.00093) 
2 correlations significant at the adjusted alpha (two tailed): *p<0.05; **p<0.01; 
Table 4. Summary of mediation analyses for Model 1 and Model 2. IV-independent 
variable; DV - dependent variables; BDCAF - severity of BD symptoms; P-Pain, EN 
= Energy level, CQ = Consequences, ID - Identity, ER - Emotional Representation, 
CS - Concerns 
IV a-paths
(IV -> M)
M b-paths
(M ->DV)
DV Indirect effect 
an x bn 
95 % 
CI of indirect 
effect 
Model 1 
BDCAF a1=0.40*** CQ b1=0.33*** P a1xb1=0.13** nz0.009, 0.32 
BDCAF a2=0.41*** ID b2=0.26*** P a2xb2=0.11** nz0.06,0.26 
BDCAF a3=-0.15 CS b3=0.02 P a3xb3=-0.001 -0.04,0.03
BDCAF a4=0.37*** ER b4=-0.09 P a4xb4=-0.008 -0.09,0.07
c=0.091, p=.11 
Total effect := c+a1xb1+a2xb2+a3xb3+a4xb4 = 0.32, p<.001, CI [0.28, 0.64] 
Contrast :=a2xb2 – a1xb1 = 0.026, p = .69 
Model 2 
BDCAF a1=0.40*** CQ b1=0.12 EN a1xb1=0.05 -0.001,0.11
BDCAF a2=0.41*** ID b2=0.06 EN a2xb2=0.02 -0.03,0.09
BDCAF a3=-0.15 CS b3=0.21* EN a3xb3=-0.03 -0.01,0.03
BDCAF a4=0.37*** ER b4=0.29*** EN a4xb4=0.11** nz0.05,0.18 
c=0.045, p=.45 
Total effect := c+a1xb1+a2xb2+a3xb3+a4xb4 = 0.19, p=.005, CI [0.06,0.32] 
Contrast :=a4xb4 – a3xb3 = 0.139, p = .003 
a-paths, b-paths – standardized estimates
95% CI – confidence intervals (bias-corrected, based on 1,000 bootstrap re-
samples)
nz 95 % CI does not include zero
*p<0.05; **p<0.01; ***p<0.001
1 
2 
3 
